The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: Two controlled clinical trials

Journal of the American Dental Association

Volumn 137, Issue 11, 2006, Pages 1572-1581

  Moore, Paul A ^a,b   Boynes, Sean C ^b   Hersh, Elliot V ^c   DeRossi, Scott S ^c   Sollecito, Thomas P ^c   Goodson, J Max ^d   Leonel, Juliana S ^d   Floros, Constantinos ^d   Peterson, Carrie ^e   Hutcheson, Matthew ^f  

^a Department of Pharmacology ^*  (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d FORSYTH INSTITUTE   (United States)

^e Novocol Pharmaceutical of Canada   (Canada)

^f Tegra Analytics   (United States)

Author keywords

Articaine; Clinical trial; Dentistry; Epinephrine; Local anesthesia

Indexed keywords

EID: 33845283870     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2006.0093     Document Type: Article

References (19)

1. Goulet JP, Perusee R, Turcotte JY. Contraindications to vasoconstrictors in dentistry, part III: pharmacologic interactions. Oral Surg Oral Med Oral Pathol 1992;74(5):692-7.
2. Little JW. Dental management of the medically compromised patient. 6th ed. St. Louis: Mosby; 2002.
3. Perusse R, Goulet JP, Turcotte JY. Contraindications to vasoconstrictors in dentistry, part I: cardiovascular diseases. Oral Surg Oral Med Oral Pathol 1992;74(5):679-86.
4. Sapira JD, Bron K. Human epinephrine secretion: direct measurement of secretions of epinephrine from the human adrenal medulla. J Clin Endocrinol Metab 1971;33(3):436-42.
5. Lipp M, Dick W, Daublander M, Fuder H, Stanton-Hicks M. Exogenous and endogenous plasma levels of epinephrine during treatment under local anesthesia. Reg Anesth 1993;18(1):6-12.
6. Troullos ES, Goldstein DS, Hargreaves KM, Dionne RA. Plasma epinephrine levels and cardiovascular response to high administered doses of epinephrine contained in local anesthesia. Anesth Prog 1987;34(1):10-3.
7. Cowan A. Clinical assessment of a new local anesthetic agent: carticaine. Oral Surg Oral Med Oral Pathol 1977;43(2):174-80.
8. Malamed SF, Gagnon S, Leblanc D. Articaine hydrochloride: a study of the safety of a new amide local anesthetic. JADA 2001; 132(2):177-85.
9. Winther JE, Nathalang B. Effectivity of a new local analgesic Hoe 40 045. Scand J Dent Res 1972;80(4):272-8.
10. Lemay H, Albert G, Helie P, et al. Articaine in conventional dental operations. J Can Dent Assoc 1984;50(9):703-8.
11. Finder RL, Moore PA. Adverse drug reactions to local anesthesia. Dent Clin North Am 2002;46(4):747-57.
12. Daublander M, Muller R, Lipp MD. The incidence of complications associated with local anesthesia in dentistry. Anesth Prog 1997;44(4):132-41.
13. Haas DA, Lennon D. A 21 year retrospective study of reports of paresthesia following local anesthetic administration. J Can Dent Assoc 1995;61(4):319-30.
14. Winther JE, Patirupanusara B. Evaluation of carticaine: a new local anesthetic. Int J Oral Surg 1974;3(6):422-7.
15. Tofoli GR, Ramacciato JC, de Oliveira PC, Volpato MC, Groppo FC, Ranali J. Comparison of effectiveness of 4% articaine associated with 1:100,000 or 1:200,000 epinephrine in inferior alveolar nerve blocks. Anesth Prog 2003;50(4):164-8.
16. Moore PA. Manual of local anesthesia in dentistry. 4th ed. Rochester, N.Y.: Eastman Kodak; 1996.
17. Malamed SF. Handbook of local anesthesia. 4th ed. St. Louis: Mosby; 1997.
18. Costa CG, Tortamano IP, Rocha RG, Francischone CE, Tortamano N. Onset and duration periods of articaine and lidocaine on maxillary infiltration. Quintessence Int 2005;36(3):197-201.
19. McLean C, Reader A, Beck M, Meryers WJ. An evaluation of 4% prilocaine and 3% mepivacaine compared with 2% lidocaine (1:100,000 epinephrine) for inferior alveolar nerve block. J Endod 1993; 19(3):146-50.